Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology

Journal of Laboratory and Clinical Medicine

Volumn 141, Issue 2, 2003, Pages 91-101

  Sutters, Michael ^a   Germino, Gregory G ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; POLYCYSTIN;

CELL PROLIFERATION; EPITHELIUM CELL; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MOLECULAR CLONING; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW;

EID: 0037320210     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2003.13     Document Type: Review

References (85)

1. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 994;77:881-94.
2. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995;81:89-98.
3. Burn TC, Connors TD, Dackowski WR, Petry LR, Van Raay TJ, Millholland JM, et al. The American PKD1 Consortium (APKD1 Consortium). Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 1995;4:575-82.
4. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339-42.
5. Sandford R, Sgotto B, Aparicio S, Brenner S, Vaudin M, Wilson RK, et al. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet 1997;6:1483-9.
6. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151-60.
7. Ponting CP, Hofmann K, Bork P. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr Biol 1999;9:R585-8.
8. Bateman A, Sandford R. The PLAT domain: a new piece in the PKD1 puzzle. Curr Biol 1999;9:R588-90.
9. Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T, et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 1998;251:625-31.
10. Moy GW, Mendoza LM, Schulz JR, Swanson WJ, Glabe CG, Vacquier VD. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 1996;133:809-17.
11. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997;16:179-83.
12. Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A 1997;94:6965-70.
13. Wu G, Somlo S. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol Genet Metab 2000;69:1-15.
14. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996;87:979-87.
15. Pei Y, Watnick T, He N, Wang K, Liang Y, Parfrey P, et al. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999;10:1524-9.
16. Watnick T, He N, Wang K, Liang Y, Parfrey P, Hefferton D, et al. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet 2000;25:143-4.
17. Koptides M, Hadjimichael C, Koupepidou P, Pierides A, Constantinou Deltas C. Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet 1999;8:509-13.
18. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, et al. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997;17:179-81.
19. Pritchard L, Sloane-Stanley JA, Sharpe JA, Aspinwall R, Lu W, Buckle V, et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet 2000;9:2617-27.
20. Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, et al. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 2001;10:2385-96.
21. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A 2001;98:12174-9.
22. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 2000;97:1731-6
23. Wu G, Markowitz GS, Li L, D'Agati VD, Factor SM, Geng L, et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 2000;24:75-8.
24. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998;93:177-88.
25. Baert L. Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int 1978;13:519-25.
26. Grantham JJ, Geiser JL, Evan AP. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 1987;31:1145-52.
27. Huseman R, Grady A, Welling D, Grantham J. Macropuncture study of polycystic disease in adult human kidneys. Kidney Int 1980;18:375-85.
28. Evan AP, Gardner KD Jr, Bernstein J. Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease. Kidney Int 1979;16:743-50.
29. Lanoix J, D'Agati V, Szabolcs M, Trudel M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 1996;13:1153-60.
30. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG. Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 1995;5:1462-8.
31. Trudel M, D'Agati V, Costantini F. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 1991;39:665-71.
32. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995;333:18-25.
33. waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002;109:157-168.
34. Boletta A, Qian F, Onuchic LF, Bhunia AK, Phakdeekitcharoen B, Hanaoka K, et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell 2000;6:1267-73.
35. Calvet JP. Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation? Kidney Int 1993;43:101-8.
36. Grantham JJ. Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis 1990;15:110-6.
37. Bacallao RL, Carone FA. Recent advances in the understanding of polycystic kidney disease. Curr Opin Nephrol Hypertens 1997;6:377-83.
38. Adler PN, Lee H. Frizzled signaling and cell-cell interactions in planar polarity. Curr Opin Cell Biol 2001;13:635-40.
39. Yoder BK, Tousson A, Millican L, Wu JH, Bugg CE Jr, Schafer JA, et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am J Physiol Renal Physiol 2002;282:F541-52.
40. Hou X, Mrug M, Yoder BK, Lefkowitz EJ, Kremmidiotis G, D'Eustachio P, et al. Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J Clin Invest 2002;109:533-40.
41. Greger R. The membrane transporters regulating epithelial NaCl secretion. Pflugers Arch 1996;432:579-88.
42. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 2000;62:535-72.
43. Ye M, Grantham JJ. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:310-3.
44. Davidow CJ, Maser RL, Rome LA, Calvet JP, Grantham JJ. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant potycystic kidney disease epithelium in vitro. Kidney Int 1996;50:208-18.
45. Sullivan LP, Wallace DP, Grantham JJ. Epithelial transport in polycystic kidney disease. Physiol Rev 1998;78:1165-91.
46. Yanase M, Handler JS. Adenosine 3′,5′-cyclic monophosphate stimulates chloride secretion in A6 epithelia. Am J Physiol 1986;251:C810-4.
47. Letz B, Korbmacher C. cAMP stimulates CFTR-like C1- channels and inhibits amiloride-sensitive Na+ channels in mouse CCD cells. Am J Physiol 1997;272:C657-66.
48. Grantham JJ, Wallace DP. Return of the secretory kidney. Am J Physiol Renal Physiol 2002;282:F1-9.
49. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 1997;30:703-9.
50. Gandhi R, Elble RC, Gruber AD, Schreur KD, Ji HL, Fuller CM, et al. Molecular and functional characterization of a calcium-sensitive chloride channel from mouse lung. J Biol Chem 1998;273:32096-101.
51. - secretion in a mouse renal inner medullary collecting duct cell line. J Physiol 2000;523:325-38.
52. + absorption in M-1 mouse cortical collecting duct cells. J Physiol 2000;524:77-90.
53. Viana F, de Smedt H, Droogmans G, Nilius B. Calcium signaling through nucleotide receptor P2Y2 in cultured human vascular endothelium. Cell Calcium 1998;24:117-27.
54. Somlo S, Ehrlich B. Human disease: calcium signaling in polycystic kidney disease. Curr Biol 2001;11:R356-60.
55. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002;4:191-7.
56. Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, et al. Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol Renal Physiol 2002;282:F763-75.
57. - secretion in colonic epithelial cells expressing high levels of cystic fibrosis transmembrane conductance regulator. J Biol Chem 1992;267:5575-83.
58. Moberly JB, Fanestil DD. Heterogeneity of expression of apical membrane determinants in A6 epithelial cells. Am J Physiol 1987;253:C37-44.
59. Arthur JM. The MDCK cell line is made up of populations of cells with diverse resistive and transport properties. Tissue Cell 2000;32:446-50.
60. Boletta A, Qian F, Onuchic LF, Bragonzi A, Cortese M, Deen PM, et al. Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis 2001:38:1421-9.
61. van Adelsberg J. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney. Dev Genet 1999;24:299-308.
62. Weston BS, Bagneris C, Price RG, Stirling JL. The polycystin-1 C-type lectin domain binds carbohydrate in a calcium-dependent manner, and interacts with extracellular matrix proteins in vitro. Biochim Biophys Acta 2001;1536:161-76.
63. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet 2000;9:1641-9.
64. Ong AC. Polycystin expression in the kidney and other tissues: complexity, consensus and controversy. Exp Nephrol 2000;8:208-14.
65. Nauta J, Goedbloed MA, van den Ouweland AM, Nellist M, Hoogeveen AT. Immunological detection of polycystin-1 in human kidney. Histochem Cell Biol 2000;113:303-11.
66. Obermuller N, Gallagher AR, Cai Y, Gassler N, Gretz N, Somlo S, et al. The rat pkd2 protein assumes distinct subcellular distributions in different organs. Am J Physiol 1999;277:F914-25.
67. Kim E, Arnould T, Sellin L, Benzing T, Comella N, Kocher O, et al. Interaction between RGS7 and polycystin. Proc Natl Acad Sci U S A 1999;96:6371-6.
68. Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Gruning W, et al. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999;274:4947-53.
69. Arnould T, Kim E, Tsiokas L, Jochimsen F, Gruning W, Chang JD, et al. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem 1998;273:6013-8.
70. Delmas P, Nomura H, Li X, Lakkis M, Luo Y, Segal Y, et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem 2002;277:11276-83.
71. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, et at. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000;408:990-4.
72. Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, Sukhatme VP. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A 1999;96:3934-9.
73. Sutters M, Yamaguchi T, Maser RL, Magenheimer BS, St John PL, Abrahamson DR, et al. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int 2001;60:484-94.
74. Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 2000;57:1460-71.
75. Hanaoka K, Guggino WB. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 2000;11:1179-87.
76. Charron AJ, Nakamura S, Bacallao R, Wandinger-Ness A. Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J Cell Biol 2000;149:111-24.
77. Stoos BA, Naray-Fejes-Toth A, Carretero OA, Ito S, Fejes-Toth G. Characterization of a mouse cortical collecting duct cell line. Kidney Int 1991;39:1168-75.
78. Schumacher K, Klotz-Vangerow S, Tauc M, Minuth WW. Embryonic renal collecting duct cell differentiation is influenced in a concentration-dependent manner by the electrolyte environment. Am J Nephrol 2001;21:165-75.
79. Chauvet V, Qian F, Boute N, Cai Y, Phakdeekitacharoen B, Onuchic LF, et al. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. Am J Pathol 2002;160:973-83.
80. Nickel C, Benzing T, Sellin L, Gerke P, Karihaloo A, Liu ZX, et al. The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells. J Clin Invest 2002;109:481-9.
81. Koochekpour S, Jeffers M, Wang PH, Gong C, Taylor GA, Roessler LM, et al. The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol 1999;19:5902-12.
82. Huber SM, Braun GS, Segerer S, Veh RW, Horster MF. Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels. Am J Renal Physiol 2000;279:F65-76.
83. Broackes-Carter FC, Mouchet N, Gill D, Hyde S, Bassett J, Harris A. Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum Mol Genet 2002;11:125-31.
84. - secretory capacity by butyrate. J Clin Invest 1998;101:2072-9.
85. Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE. The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 1998;361:299-309.